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Abstract 
A full remotely powered system for metabolism 
monitoring of free-moving mice is presented here. The 
fully implantable sensing platform hosts two ASICs, one 
off-the-shelf micro-controller, four biosensors, two other 
sensors, a coil to receive power, and an antenna to 
transmit data. Proper enzymes ensure specificity for 
animal metabolites while Multi-Walled Carbon 
Nanotubes ensure the due sensitivity. The remote 
powering is indeed provided by inductive coils located 
under the floor of the mouse' cage. Two different 
approaches where investigated to ensure freedom of 
movement to the animal. The application to studies for 
personalized medicine is demonstrated by showing 
continuous monitoring of both glucose and paracetamol. 
 
I. INTRODUCTION 
Translational medicine is an extremely effective approach to 
progress in diseases characterization as well as in identifying 
and optimizing new therapeutic treatment [1]. The use of 
small animal, like mice, is recommend to save time and 
money. The extremely reduced sizes of a mouse (only 5 cm in 
length) pose technological challenges in developing 
extremely tiny and highly integrated fully implantable chip to 
monitor its metabolism. The further request to allow free-
movements to the mouse as well as to avoid animal stress 
impose further challenges on the system powering. The size 
of the implant needs to be small and lightweight for the 
comfort of the animal. Therefore, the implant should be 
batteryless. The magnetic field is one of the most well known 
solutions for remote powering [2]. The power is delivered to 
an implant by using a magnetically coupled coil pair. This 
study presents a fully implantable device for remote 
monitoring of mice metabolism in study related to 
personalized medicine by investigating two different 
powering approaches to allow free movement to the animal. 
 
II THE FULLY IMPLANTABLE DEVICE 
A. The Device Architecture 
The whole fully implantable device is build out of three main 
different sub-units (Fig. 1): (i) a passive chip realized on 
silicon substrate that hosts four different biosensors plus one 
temperature (T) and a pH sensor; (ii) an intermediate layer 
realized on PCB (Printed Circuit Board) that hosts two 
dedicated ASIC ICs and an off-the-shelf microcontroller; (iii) 
one coil at the bottom that behave as receiving antenna to 
power the whole device. 
 
Fig. 1. The system architecture of the implantable device  
 
B. The Fabrication of the Passive Chip 
The micro fabrication of the passive chip was realized with a 
two-masks process flow. Silicon wafers with 500 nm of 
native oxide were chosen as substrate. Chip metallization was 
realized by evaporation of 10 nm of Ti, followed by 100 nm 
of Pt. Metal passivation was made via atomic layer deposition 
of Al2O3 followed by dry etching with Argon Ion Milling. 
Details on the process flow can be found in [3]. The platform 
measures 12x11 mm in order to fit the size of the coil (12x12 
mm) and the wire bonding. The platform hosts an array of 
four independent cells in the three-electrode configuration. 
All electrodes are made in Pt. 
 
C. The Functionalization of the Biosensors 
For the glucose measurement, the working electrodes were 
nanostructured with 0.3 µg MWCNTs by drop cast, followed 
by the drop cast of 2 µl of a glucose oxidase solution (15 
mg/ml), as reported in [3]. For the drug measurements 
(Paracetamol), the electrodes were used without 
modifications. 
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Fig. 2. The architecture of the frontend IC 
 
 
III THE ASIC ICS 
 
A. The Sensors Frontend 
A mixed-mode IC is implemented to interface the sensor 
array. The block diagram of the interface IC (IC) is shown in 
Fig. 2, together with its connections with the sensor and other 
devices on the platform. The IC controls and reads out four 
bio-molecular sensors, as well as a pH sensor and a 
temperature sensor for calibration. The IC supports both 
cyclic voltammetry (CA) and chronoamperometry (CV). 
Different voltage profiles are generated to control CV and CA 
by using a single fully on-chip waveform generator. The IC 
reads out the electrochemical sensors and streams out the 
digitized measured data. The streamed out data is given to the 
other IC to be transmitted. The waveform generator is 
commanded from a standard interface. The required 
commands are provided by a tiny commercial micro-
controller. The IC is implemented in 0.18 um technology and 
consumes 0.93 mW from 1.8 V supply voltage. Electrical 
measurements show that the readout current range is 1650 nA 
with 8-bit resolution. More details on the design and its 
testing are reported in [4]. 
 
B. The Energy Manager 
On-chip implantable solution is composed of power 
management circuits. The induced AC voltage on the implant 
coil is converted to a DC voltage by a passive rectifier and a 
clean and stable 1.8 V supply voltage is created by a low 
drop-out voltage regulator [5]. 
 
IV THE PACKAGING OF THE IMPLANT 
 
A. The Sensors Frontend 
The epoxy adhesive (EP42HT-2Med system) was used to 
assembly the PCB with the antenna and the electronic 
component, with the sensing platform. The interconnections 
between the platinum pads of the passive chip and the gold 
pads on the PCB were realized with Al wire bonding and 
were protected with a glob top protection of 0.3 mm.  
 
 
Fig. 3. Coil array powering system 
 
 
Fig. 4. Drawback of the coil array powering solution 
 
Two subsequent 5 µm layers of Parylene C were deposited by 
chemical vapor deposition using a Comelec C-30-S Parylene 
Deposition System. Parylene C was used to cover the whole 
device but not the electrode array that needs to be in contact 
with fluids. A biocompatible Silicone (NuSil MED-6233), 
was used to cover the edges and to fill the spaces between the 
platform and the PCB. Finally, the electrodes were 
functionalized for the electrochemical measurements as 
previously described. 
 
 
V THE REMOTE POWERING SYSTEMS 
 
A. Coil Array 
The implant requires continue power for any position of the 
animal in the cage meanwhile the animal must move freely 
inside. Accordingly, a coil array is implemented to cover all 
the bottom of the cage and transfer the power to the implant.  
.3 shows the approach with the coil array. The powering coils 
are driven by class-E power amplifiers at 13.56 MHz 
frequency. Each power amplifier is optimized for maximum 
power transfer efficiency [6]. The power transfer efficiency 
decreases when the implantable system moves from the 
center to the edges of the powering coil. Therefore, the 
transferred powered needs to be increased to keep the 
implantable system active. However, after a certain distance 
from center, the remote powering signal creates significant 
noise on the communication band due to the increased 
transfer power. Accordingly, there are some dead zones 
where the transfer efficiency decreases drastically and also 
the communication becomes crucial as shown in Fig. 3. In 
addition, the powering coils create large noise on the remote 
powering signal when all the coils are active as shown in Fig. 
4. This noise can be suppressed by adding extra capacitors to 
the output of the rectifier [5]. However, the digital control 
block of the implantable system demands abrupt supply 
voltage to initialize properly.  
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B. Servo-Controlled Moving system 
In this second approach, we propose a servo-controlled 
remote powering system that locates the animal in the cage 
and delivers the power to the implantable system efficiently 
[7]. Fig. 5 shows the servo-controlled remote powering 
system of the implantable system. The system has two X and 
Y axes rails to move the powering coil under the cage 
according to the position of the animal in the cage. In order to 
define the animal position, a permanent magnet is tracked and 
monitored by the magnetic field sensors. The powering coil is 
driven by an efficient class-E type power amplifier that is 
optimized at 13.56 MHz. The servo-controlled system helps 
to keep the powering coil position aligned to the implantable 
system to efficiently transfer the power, which decreases the 
noise of the power amplifier on the communication frequency 
band. Therefore, a reliable data transmission is achieved. The 
aforementioned noise due to using multiple coil for remote 
powering is also suppressed since single powering coil is 
used to the power transfer as shown in Fig. 3. 
 
VI THE REMOTE MONITORING SYSTEM 
 
A. The Architecture for Receiving Data 
The implantable platform has onboard a frontend chip [4] that 
provides the 8/10 bits coded information of the current signal 
flowing inside the biosensors as a digital word of 20 bits. This 
signal drives an 869 MHz OOK transmitter [6], which 
modulates this information in order to be processed by the 
external reader. The external reader is composed of three 
main parts compose the last one: the demodulator, the 
Bluetooth transmitter and the Android interface 
 
B. The Demodulator 
 
An custom designed antenna receives the modulated 
signal from the implantable chip with the tuned radio 
frequency receiver. The output (Vf) is sent to a former project 
board [6], which is a tuned RF receiver. The receiver is able 
to clean the signal and give to it the same waveform of the 
original one provided by the chip inside the implantable 
platform due to the logarithmic amplifier and a high-speed 
comparator (Fig. 6). 
 
 
Fig. 5. Servo-controlled remote powering system 
 
 
Fig. 6. Demodulator [6] 
C. Bluetooth Transmitter 
The cleaned digital signal is sent to another board which is in 
charge of analyze, validate and transmit via Bluetooth the 
data to the Android interface. The on-board microcontroller is 
able to sample each bit of the digital signal (Dataout), decode 
it and understand if a transmission error has occurred. When 
the data has been validated, is sent by the well-known UART 
protocol to a commercial Bluetooth module as a word of two 
bytes. 
 
D. Android Interface 
For a continuous monitoring of the concentration of the 
substances we want to measure, an android application has 
been developed starting from a previous work [8]. The most 
important improvement is the possibility to zoom the curves 
and to filter the noise with many filtering techniques (moving 
average, median value, IIR filter, ecc…) while the interface is 
acquiring and plot the data in time. Reliability and data space 
occupation has been optimized in order to let the user save a 
significant number of curves according to the big external 
flash memory of the device, which can be any tablet or 
smartphone. 
 
 
 
VII SYSTEM IN-VITRO TESTS 
 
A. Electrochemical Measurements 
Electrodes were tested for glucose or Paracetamol sensitivity 
with chronoamperometry at +650 mV. The sensors were 
covered with 200 µl of a 100mM phosphate buffered saline 
(PBS) solution (pH 7.4), and then tested against solutions at 
increasing concentration of glucose or Paracetamol.  
 
 
 
Fig. 7. Chronoamperometry on the Android interface 
1776
  
Fig. 8. Calibration curve for paracetamol 
 
Sensitivity and limit of detection (LOD) were evaluated after 
linear regression of the data, according to [9]. Measurements 
with glucose and Paracetamol were carried out with both the 
fixed coil and the intelligent moving remote powering 
systems. Here we report the calibration obtained with the 
moving powering system. To perform a calibration, the chip 
was kept at a fixed position and the chip was covered with 
200 µl of PBS at increasing concentrations of glucose or 
Paracetamol. Calibration lines (one example reported in Fig. 
8) are calculated from the evaluation of the current steps, by 
measuring the difference between the reached current value 
and the baseline (corresponding to the current at 0 µM of 
glucose or Paracetamol). For glucose we obtained a 
sensitivity of 1.3±0.4 nA/mMmm2 and a LOD of 0.2± 0.1µM, 
which is relevant in many clinical applications. Many other 
metabolites of clinical interest (e.g. lactate, glutamate) can be 
monitored with our sensing platform, by changing the 
enzyme that is employed for the electrode functionalization. 
The anti-inflammatory drugs Paracetamol was monitored 
with the same system.  We obtained a sensitivity of 1.7±0.5 
nA/mMmm2 and a LOD of 12±9 µM, which is compatible 
with the physiological range for Paracetamol [10]. 
 
B. Data Acquisition with the Moving System 
We also performed measurements where the chip was moved 
in the cage in order to test the capability of the intelligent 
powering system to track the chip position, to transfer the 
power and the ability of the receiving system to acquire the 
data and showing them on the tablet. The data stream in Fig. 
9 clearly shows that during the displacement no data are 
transmitted. 
VIII CONCLUSIONS 
We investigated two approaches for the remote powering of a 
fully implantable multi-panel device for translational 
medicine. The first approach proposes a series of coils 
powering the implant once the mouse is located on top of 
them. The second approach presents a single coil that follows 
the mouse thanks to a magnet located in the implant and a 
robot that moves the coil. The multi-coils system presents 
limitations dealing with "dead zones" of powering in the cage 
while the moving-coil ensures better continuity on powering 
to the implant thanks to the good performance of the feed-
back and actuation system.  
 
Fig. 9. Data stream during chip displacement in the cage 
 
By using this second approach, the continuous monitoring of 
both a disease marker (glucose) and a therapeutic compound 
(paracetamol) was demonstrated. 
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